TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

TPEX:4157 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,001	8,219	10,911	11,505	11,039	16,380
Market Cap Growth	27.24%	-24.67%	-5.16%	4.22%	-32.60%	24.19%
Enterprise Value	9,221	7,222	10,169	10,545	10,032	15,984
Last Close Price	14.05	11.45	15.20	16.05	15.40	22.85
PE Ratio	-	-	79.80	-	14.23	-
PS Ratio	258.12	54.56	88.61	317.56	8.53	699.34
PB Ratio	11.20	7.59	9.75	11.86	8.81	37.04
P/TBV Ratio	11.20	7.68	9.87	11.86	8.81	37.07
P/FCF Ratio	416719.24	-	3055.51	-	17.84	-
P/OCF Ratio	20042.61	-	1462.83	-	17.55	-
EV/Sales Ratio	237.98	47.94	82.59	291.05	7.75	682.43
EV/EBITDA Ratio	-	-	-	-	11.03	-
EV/EBIT Ratio	-	-	-	-	11.15	-
EV/FCF Ratio	384202.61	-	2847.73	-	16.21	-
Debt / Equity Ratio	0.09	0.05	0.07	0.04	0.04	0.04
Debt / EBITDA Ratio	-	-	-	-	0.06	-
Debt / FCF Ratio	3395.79	-	20.92	-	0.09	-
Asset Turnover	0.04	0.13	0.11	0.03	1.33	0.03
Inventory Turnover	0.37	0.42	0.46	0.23	0.78	0.36
Quick Ratio	9.99	22.49	22.38	17.97	13.41	3.86
Current Ratio	10.79	23.57	23.19	18.50	13.71	4.13
Return on Equity (ROE)	-18.36%	-3.51%	13.09%	-21.33%	91.47%	-64.39%
Return on Assets (ROA)	-9.62%	-6.35%	-9.59%	-14.23%	57.68%	-25.57%
Return on Invested Capital (ROIC)	-134.26%	-88.22%	-125.41%	-112.72%	311.53%	-165.06%
Return on Capital Employed (ROCE)	-18.60%	-10.80%	-14.80%	-27.90%	69.00%	-66.60%
Earnings Yield	-1.84%	-0.47%	1.25%	-2.06%	7.03%	-2.47%
FCF Yield	0.00%	-2.11%	0.03%	-0.21%	5.61%	-1.51%
Buyback Yield / Dilution	0.06%	-0.03%	-0.06%	0.07%	-0.07%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.